Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Synthesis and evaluation of a novel synthetic phosphocholine lipid-AZT conjugate that double-targets wild-type and drug resistant variants of HIV.

Kucera LS, Morris-Natschke SL, Ishaq KS, Hes J, Iyer N, Furman PA, Fleming RA.

Nucleosides Nucleotides Nucleic Acids. 2004;23(1-2):385-99.

PMID:
15043162
2.

Phospholipid analogs against HIV-1 infection and disease.

Morris-Natschke SL, Ishaq KS, Kucera LS.

Curr Pharm Des. 2003;9(18):1441-51. Review.

PMID:
12769724
3.

Cellular metabolism in lymphocytes of a novel thioether-phospholipid-AZT conjugate with anti-HIV-1 activity.

Kucera GL, Goff CL, Iyer N, Morris-Natschke S, Ishaq KS, Wyrick SD, Fleming RA, Kucera LS.

Antiviral Res. 2001 May;50(2):129-37.

PMID:
11369433
4.
5.

In vitro evaluation and characterization of newly designed alkylamidophospholipid analogues as anti-human immunodeficiency virus type 1 agents.

Kucera LS, Iyer N, Morris-Natschke SL, Chen SY, Gumus F, Ishaq K, Herrmann DB.

Antivir Chem Chemother. 1998 Mar;9(2):157-65.

PMID:
9875387
6.

Amplified Assay for Specific Dual-Labeled DNA Using the Coagulation Cascade (EDNA-ELCA).

Doellgast GJ, Beard GA, Sheehan M, Iyer N, Kucera LS, Richardson SH.

Methods Mol Med. 1999;26:197-216. doi: 10.1385/0-89603-518-2:197.

PMID:
21340879
8.

Salmonellae activate tumor necrosis factor alpha production in a human promonocytic cell line via a released polypeptide.

Ciacci-Woolwine F, Kucera LS, Richardson SH, Iyer NP, Mizel SB.

Infect Immun. 1997 Nov;65(11):4624-33.

9.

Synthesis and evaluation of novel thymidine analogs as antitumor and antiviral agents.

Chen X, Bastow K, Goz B, Kucera LS, Morris-Natschke SL, Ishaq KS.

J Med Chem. 1996 Aug 16;39(17):3412-7.

PMID:
8765526
10.

Synthesis and antiproliferative and antiviral activity of 2'-deoxy-2'-fluoroarabinofuranosyl analogs of the nucleoside antibiotics toyocamycin and sangivamycin.

Krawczyk SH, Nassiri MR, Kucera LS, Kern ER, Ptak RG, Wotring LL, Drach JC, Townsend LB.

J Med Chem. 1995 Sep 29;38(20):4106-14.

PMID:
7562946
11.

Membrane-interactive phospholipids inhibit HIV type 1-induced cell fusion and surface gp160/gp120 binding to monoclonal antibody.

Krugner-Higby L, Goff D, Edwards T, Iyer N, Neufeld J, Kute T, Morris-Natschke S, Ishaq K, Piantadosi C, Kucera LS.

AIDS Res Hum Retroviruses. 1995 Jun;11(6):705-12.

PMID:
7576930
12.

Regulation of macrophage activation and human immunodeficiency virus production by invasive Salmonella strains.

Mizel SB, Kucera LS, Richardson SH, Ciacci F, Iyer NP.

Infect Immun. 1995 May;63(5):1820-6.

13.

Activity of triciribine and triciribine-5'-monophosphate against human immunodeficiency virus types 1 and 2.

Kucera LS, Iyer NP, Puckett SH, Buckheit RW Jr, Westbrook L, Toyer BR, White EL, Germany-Decker JM, Shannon WM, Chen RC, et al.

AIDS Res Hum Retroviruses. 1993 Apr;9(4):307-14.

PMID:
7685612
14.

Priming of rabbit alveolar macrophages for enhanced oxidative responses by herpes simplex virus type 2 infection.

Giridhar G, Hayakawa H, Kucera LS, Myrvik QN.

J Leukoc Biol. 1991 May;49(5):442-8.

PMID:
1849952
15.

Synthesis and evaluation of novel ether lipid nucleoside conjugates for anti-HIV-1 activity.

Piantadosi C, Marasco CJ Jr, Morris-Natschke SL, Meyer KL, Gumus F, Surles JR, Ishaq KS, Kucera LS, Iyer N, Wallen CA, et al.

J Med Chem. 1991 Apr;34(4):1408-14.

PMID:
1901911
17.

Novel membrane-interactive ether lipid analogs that inhibit infectious HIV-1 production and induce defective virus formation.

Kucera LS, Iyer N, Leake E, Raben A, Modest EJ, Daniel LW, Piantadosi C.

AIDS Res Hum Retroviruses. 1990 Apr;6(4):491-501.

PMID:
1692729
18.

Studies of phospholipase and cyclooxygenase activities in herpes simplex virus type 2-transformed rat cells.

Heitman CR, Waite M, Kucera LS.

Carcinogenesis. 1989 Nov;10(11):2059-65.

PMID:
2509090
19.

Herpes simplex virus type 2 infection of unstimulated human T-lymphocytes.

Kucera LS, Raben D, Iyer N, Ricardo MJ Jr.

Viral Immunol. 1989;2(1):11-6.

PMID:
2545223
20.
21.

L-fucose, D-mannose, L-galactose, and their BSA conjugates stimulate macrophage migration.

Takata I, Chida K, Gordon MR, Myrvik QN, Ricardo MJ Jr, Kucera LS.

J Leukoc Biol. 1987 Mar;41(3):248-56.

PMID:
3031190
22.
23.

Lipid composition of alveolar macrophage plasma membrane during postnatal development.

Ricardo MJ Jr, Small GW, Myrvik QN, Kucera LS.

J Immunol. 1986 Feb 1;136(3):1054-60.

PMID:
3001185
24.

Immunologic characterization of herpes simplex virus type 2 antigens ICP10 and ICSP11/12.

Flanders RT, Kucera LS, Raben M, Ricardo MJ Jr.

Virus Res. 1985 Apr;2(3):245-60.

PMID:
2988230
28.

Detection of herpes simplex virus type 2 glycoproteins expressed in virus-transformed rat cells.

Lewis JG, Kucera LS, Eberle R, Courtney RJ.

J Virol. 1982 Apr;42(1):275-82.

29.

Phospholipid synthesis in human embryo fibroblasts infected with herpes simplex virus type 2.

Daniel LW, Waite M, Kucera LS, King L, Edwards I.

Lipids. 1981 Sep;16(9):655-62.

PMID:
6270493
30.
31.

Parameters distinguishing herpes simplex virus type 2-transformed tumorigenic and nontumorigenic rat cells.

Hale AH, Kucera LS, Daniel LW, Waite M.

Cancer Res. 1981 Feb;41(2):629-34. No abstract available.

32.

Metabolism of fatty acids by cultured tumor cells and their diploid precursor fibroblasts.

Daniel LW, Kucera LS, Waite M.

J Biol Chem. 1980 Jun 25;255(12):5697-702. No abstract available.

33.

Herpes simplex virus-host cell interactions.

Kucera LS.

CRC Crit Rev Microbiol. 1979 Nov;7(3):215-44. Review. No abstract available.

PMID:
232032
34.

Stimulation of human cell DNA synthesis by defective herpes simplex virus type 2.

Marcon MJ, Kucera LS.

Virology. 1979 Oct 30;98(2):364-72. No abstract available.

PMID:
228477
35.

Serological response patterns to herpes virus type 2 early and late antigens in cervical carcinoma patients.

Heise ER, Kucera LS, Raben M, Homesley H.

Cancer Res. 1979 Oct;39(10):4022-6. No abstract available.

36.

Stimulation of human cellular thymidine kinase activity during abortive infection with herpes simplex virus type 2.

Marcon MJ, Kucera LS.

Virology. 1979 Jul 15;96(1):315-8. No abstract available.

PMID:
223308
37.
38.

Biologic and morphologic properties of a new ascites cell line derived from a Lucké renal adenocarcinoma-bearing Rana pipiens.

Kucera LS, Leake ES, Edwards IJ, Wright MJ.

J Reticuloendothel Soc. 1977 Oct;22(4):349-62. No abstract available.

PMID:
200752
39.

Oncogenic transformation of rat embryo fibroblasts with photoinactivated herpes simplex virus: rapid in vitro cloning of transformed cells.

Kucera LS, Gusdon JP, Edwards I, Herbst G.

J Gen Virol. 1977 Jun;35(3):473-85. No abstract available.

PMID:
196034
42.
43.

Letter: The oncogenic potential of dye-light treatment of herpetic lesions.

Gusdon JP Jr, Kucera LS.

Am J Obstet Gynecol. 1974 Oct 15;120(4):569-70. No abstract available.

PMID:
4370159
45.

Isolation and characterization of a cell line from the cocultivation of Lucké renal tumor cells and nontransformed feeder cells.

Kucera LS, Simonson J.

J Natl Cancer Inst. 1974 Aug;53(2):415-21. No abstract available.

PMID:
4367239
46.

Photodynamic inactivation of herpes simplex keratitis.

Tara CS, Stanley JA, Kucera LS, Hollis S.

Arch Ophthalmol. 1974 Jul;92(1):51-3. No abstract available.

PMID:
4835977
47.
49.

Induction and regulation of DNA nucleotidyltransferase activity in fish cells infected with frog virus 3.

Kucera LS, Granoff A.

Virology. 1969 Mar;37(3):455-63. No abstract available.

PMID:
4975945

Supplemental Content

Loading ...
Support Center